On 10 August 2002 at the UCI sanctioned Satum Cycling Classic, the Respondent provided a urine sample. The A sample analysis resulted in finding the prohibited anabolic steroid; 19-norandrosterone. Norandrosterone is a metabolite on the list of list of Prohibited Classes of Substances and Prohibited Methods. The Respondent was informed and he requested that the B sample would be tested. The B sample analysis confirmed the positive results of the sample analysis.
The Respondent agreed on October 6, 2002, to a provisional suspension commencing on the date of this award.
Amino acid supplements the Respondent used were delivered for testing at the Integrated Biomolecule Corporation ("IBC"), and in one sample traces of 19-norandrosterone were present. UCLA concluded in his testing that in the same sample was no presence 19-norandrosterone but contained substances with spectral characteristics of androgens.
The UCLA Lab analysis of the supplement (Tyrosine Bottle 1) and the IBC lab result are in conflict with the UCLA Lab unable to confirm the BCI analytical result. The contaminant reported by the IBC is not the parent drug but the metabolite of it usually found in the urine.
USADA determined that in accordance with article 130 section 1, of the UCI Anti-Doping Examination Regulations ("UCI AER") for the use of an anabolic steroid.
Respondent claims the supplements he uses as cause of his positive test, however the UCLA laboratory disagrees.
The evidence at the hearing unequivocally demonstrated that the chain of custody of the open bottle of 15 Capsules was totally inadequate.
Findings:
A doping infraction occurred and the Respondent is disqualified from the Saturn Cycling Classic on 8 August 2002. The Respondent's results from that race are nullified.
A ineligibility for the period of one year is ordered.
A fine CHF 700 is assessed.
The administrative fees and expenses of the American Arbitration Association and the compensation and expenses of the arbitrators shall by borne entirely by USADA.
